| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |